Compare GSK plc (GSK) vs Invesco WilderHill Clean Energy ETF (PBW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Invesco WilderHill Clean Energy ETF — how do they compare? GSK plc trades at $52.69 (market cap $101.34B), while Invesco WilderHill Clean Energy ETF trades at $33.21. The key difference: GSK plc pays a 3.49% dividend while Invesco WilderHill Clean Energy ETF pays none, and GSK plc is trading nearer its 52-week high, Invesco WilderHill Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| GSK | PBW | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | Sector/Thematic |
52-Week High | $61.18 | $46.99 |
52-Week Low | $36.20 | $22.23 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
PBW trades at $33.22, down 5.03% today amid a bearish technical signal with moving averages indicating selling pressure. The ETF shows neutral momentum oscillators but faces resistance near $35. Recent news highlights clean energy sector tailwinds from energy security concerns and legislative support, though the fund remains sensitive to interest rate movements and semiconductor market volatility.
Outlook is cautious; clean energy demand offers long-term growth, but PBW's high sensitivity to Treasury yields and tech sector swings poses near-term risks. Investors should weigh sector optimism against macroeconomic headwinds and the ETF's history of volatility during rate cycles.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →
